Stocks and Investing Stocks and Investing
Wed, November 1, 2023
Tue, October 31, 2023

Ben Hendrix Maintained (THC) at Buy with Decreased Target to $72 on, Oct 31st, 2023


Published on 2024-10-28 07:14:04 - WOPRAI, Ben Hendrix
  Print publication without navigation


Ben Hendrix of RBC Capital, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Decreased Target from $87 to $72 on, Oct 31st, 2023.

Ben has made no other calls on THC in the last 4 months.



There are 8 other peers that have a rating on THC. Out of the 8 peers that are also analyzing THC, 1 agrees with Ben's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $89 on, Tuesday, August 1st, 2023


These are the ratings of the 7 analyists that currently disagree with Ben


  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $71 on, Friday, October 20th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $94 on, Thursday, September 14th, 2023
  • Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $98 on, Monday, August 14th, 2023
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Wednesday, August 2nd, 2023
  • John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $95 on, Wednesday, August 2nd, 2023
  • Andrew Mok of "UBS" Maintained at Strong Buy with Increased Target to $104 on, Tuesday, August 1st, 2023
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, August 1st, 2023
Contributing Sources